Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis

This study aimed to evaluate the clinical efficacy and safety of 4 weekly formulations of glucagon-like peptide 1 receptor agonists (GLP-1RAs) on glycemic control, including glycemic control, by using a network meta-analysis (NMA). METHODS: PubMed, EMBASE, and Cochrane Library Central Register of Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Han, Li, Xin-Zhu, Chen, Jia-Qing, Ren, Tian-Shu, Zhang, Ying-Shi, Wang, Yi-Nuo, Zhao, Qing-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328610/
https://www.ncbi.nlm.nih.gov/pubmed/37417602
http://dx.doi.org/10.1097/MD.0000000000034122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328610/
https://www.ncbi.nlm.nih.gov/pubmed/37417602
http://dx.doi.org/10.1097/MD.0000000000034122

Ejemplares similares